Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Beijing, China.
Nanfang Hospital, Southern Medical University, Guangzhou, China.
Bone Marrow Transplant. 2019 Sep;54(9):1419-1433. doi: 10.1038/s41409-019-0449-9. Epub 2019 Jan 25.
Macrophages (MΦs) are an important immune cell population that are essential for tissue homeostasis and disease pathogenesis. MΦs are now classified as either M1, which produce pro-inflammatory cytokines, or M2, which produce antiinflammatory cytokines. The impact of granulocyte colony-stimulating factor (G-CSF) on MΦs in humans is unclear. Moreover, little is known about the association between MΦ subsets in allografts and the occurrence of acute graft-versus-host disease (aGVHD) in patients who undergo allogeneic hematopoietic stem cell transplantation (allo-HSCT). In the current study, we found that the M1/M2 ratio was markedly decreased in both G-CSF-treated bone marrow (post-BM) and G-CSF-treated peripheral blood from healthy donors. Post-BM MΦs exhibited reduced migration and increased phagocytosis. Moreover, post-BM MΦs reduced the percentage of Th1 and Tc1 lineages and increased the percentage of Th2, Tc2, and Treg lineages. Patients who received BM grafts with a higher M1/M2 ratio exhibited a higher incidence of grade 2-4 aGVHD. In summary, our data indicate that G-CSF decreases the M1/M2 ratio in BM grafts from healthy donors, which may contribute to preventing the occurrence of grade 2-4 aGVHD in patients after allo-HSCT.
巨噬细胞(MΦs)是一种重要的免疫细胞群体,对于组织内稳态和疾病发病机制至关重要。MΦs 现在被分为 M1 和 M2,M1 产生促炎细胞因子,M2 产生抗炎细胞因子。粒细胞集落刺激因子(G-CSF)对人类 MΦs 的影响尚不清楚。此外,人们对同种异体造血干细胞移植(allo-HSCT)患者移植物中 MΦ 亚群与急性移植物抗宿主病(aGVHD)发生之间的关联知之甚少。在本研究中,我们发现 G-CSF 处理的健康供者骨髓(post-BM)和 G-CSF 处理的外周血中的 M1/M2 比值明显降低。post-BM MΦ 的迁移减少,吞噬作用增加。此外,post-BM MΦ 降低了 Th1 和 Tc1 谱系的百分比,增加了 Th2、Tc2 和 Treg 谱系的百分比。接受具有更高 M1/M2 比值的 BM 移植物的患者发生 2-4 级 aGVHD 的发生率更高。总之,我们的数据表明,G-CSF 降低了健康供者 BM 移植物中的 M1/M2 比值,这可能有助于预防 allo-HSCT 后患者发生 2-4 级 aGVHD。